Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMD
2126
DELISTED
Cantel Medical Corporation
CMD
| $1.96M | ﹤0.01% |
+31,469
| New | +$1.92M |
|
2127
Brown & Brown
BRO
$23.8B
| $1.95M | ﹤0.01% |
+121,600
| New | +$1.95M |
|
2128
Crown Crafts
CRWS
$32M
| $1.95M | ﹤0.01% |
229,900
+17,600
| +8% | +$147K |
|
2129
CNB Financial Corp
CCNE
$1.04B
| $1.95M | ﹤0.01% |
108,040
+41,240
| +62% | +$758K |
|
2130
Commercial Metals
CMC
$7.98B
| $1.95M | ﹤0.01% |
+142,300
| New | +$2.12M |
|
|
EPE
2131
DELISTED
EP Energy Corporation
EPE
| $1.95M | ﹤0.01% |
444,631
-913,969
| -67% | -$4.95M |
|
|
FSYS
2132
DELISTED
FUEL SYSTEMS SOLUTIONS INC COM STK
FSYS
| $1.94M | ﹤0.01% |
397,100
+65,000
| +20% | +$371K |
|
2133
Tandem Diabetes Care
TNDM
$1.63B
| $1.94M | ﹤0.01% |
16,430
+2,547
| +18% | +$253K |
|
|
IVC
2134
DELISTED
Invacare Corporation
IVC
| $1.94M | ﹤0.01% |
111,500
+35,700
| +47% | +$644K |
|
|
NPD
2135
DELISTED
CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM
NPD
| $1.93M | ﹤0.01% |
792,400
+28,600
| +4% | +$67.6K |
|
|
JNP
2136
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| $1.93M | ﹤0.01% |
187,600
+30,900
| +20% | +$358K |
|
|
HALL
2137
DELISTED
Hallmark Financial Services, Inc.
HALL
| $1.93M | ﹤0.01% |
16,520
+3,710
| +29% | +$459K |
|
2138
Urban One Class D
UONEK
$24.1M
| $1.93M | ﹤0.01% |
112,140
-1,350
| -1% | -$26.6K |
|
|
UWN
2139
DELISTED
Nevada Gold & Casinos, Ltd.
UWN
| $1.93M | ﹤0.01% |
857,500
+37,300
| +5% | +$67.8K |
|
|
SOL
2140
DELISTED
Emeren Group
SOL
| $1.92M | ﹤0.01% |
225,713
+93,473
| +71% | +$656K |
|
|
ENBL
2141
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
| $1.92M | ﹤0.01% |
+208,623
| New | +$2.22M |
|
|
SGMO
2142
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.91M | ﹤0.01% |
209,400
-276,952
| -57% | -$2.13M |
|
2143
GSI Technology
GSIT
$260M
| $1.91M | ﹤0.01% |
512,800
+43,500
| +9% | +$178K |
|
2144
Peoples Bancorp
PEBO
$1.48B
| $1.91M | ﹤0.01% |
101,200
-20,379
| -17% | -$411K |
|
|
RXDX
2145
DELISTED
Ignyta, Inc.
RXDX
| $1.9M | ﹤0.01% |
142,100
-73,700
| -34% | -$888K |
|
|
CTG
2146
DELISTED
Computer Task Group, Inc.
CTG
| $1.9M | ﹤0.01% |
287,500
+13,800
| +5% | +$93.5K |
|
2147
First Majestic Silver
AG
$9.26B
| $1.9M | ﹤0.01% |
580,500
+448,800
| +341% | +$1.53M |
|
|
VVUS
2148
DELISTED
Vivus Inc
VVUS
| $1.89M | ﹤0.01% |
185,562
+154,839
| +504% | +$2.1M |
|
2149
James River Group Holdings
JRVR
$199M
| $1.89M | ﹤0.01% |
56,400
+38,800
| +220% | +$1.18M |
|
|
ENT
2150
DELISTED
Global Eagle Entertainment Inc.
ENT
| $1.89M | ﹤0.01% |
7,664
+5,464
| +248% | +$1.56M |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.